Aortic distensibility is closely related to the progression of left ventricular hypertrophy in patients receiving hemodialysis

Angiology

Volumn 51, Issue 11, 2000, Pages 933-941

  Matsumoto, Yuji ^a   Hamada, Mareomi ^b   Hiwada, Kunio ^b  

^a Saijo Central Hospital   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DESCENDING AORTA; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; MALE; MULTIPLE REGRESSION;

AGED; AORTA; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RENAL DIALYSIS; RISK FACTORS;

EID: 0033740012     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970005101106     Document Type: Article

References (39)

1. The prognostic importance of left ventricular geometry in uremic cardiomyopathy
2. Impact of left ventricular hypertrophy on survival in end-stage renal disease
3. Arterial blood pressure and left ventricular hypertrophy in haemodialysis patients
4. Secondary hyperparathyroidism and cardiac hypertrophy in hemodialysis patients
5. Follow-up of cardiac changes induced by anemia compensation in normotensive hemodialysis patients with left-ventricular hypertrophy
6. Left ventricular hypertrophy in end-stage renal disease
7. Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients
8. Cardiac hypertrophy and arterial alterations in end-stage renal disease: Hemodynamic factors
9. Cardiac and arterial interactions in end-stage renal disease
10. Aortic and large artery compliance in end-stage renal failure
11. Impact of aortic stiffness on survival in end-stage renal disease
12. Evaluation of aortic distensibility in patients with essential hypertension by using cine magnetic resonance
13. Non-invasive physiological assessment of vascular wall sclerosis using carotid pulse tracing and cine magnetic resonance
14. Evaluation of aortic distensibility in patients with coronary artery disease by use of cine magnetic resonance
15. Estimation of aortic wall sclerosis in hypertension by use of carotid pulse tracing and cine magnetic resonance
16. Evaluation of aortic distensibility in hemodialysis patients using cine magnetic resonance: A preliminary study
17. Effect of antihypertensive therapy on aortic distensibility in patients with essential hypertension: Comparison with trichlormethiazide, nicardipine and alacepril
18. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
19. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method
20. Increased plasma levels of adrenomedullin in patients with hypertrophic cardiomyopathy: Its relation to endothelin- 1, natriuretic peptides and noradrenaline
21. Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community
22. Effects of aortic distensibility on the cardiac force in man
23. Aortic compliance measured by non-invasive Doppler ultrasound: Description of a method and its reproducibility
24. Evaluation of aortic distensibility with transesophageal echocardiography
25. Stiffness of human arterial wall assessed by intravascular ultrasound
26. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia
27. Regional aortic compliance studied by magnetic resonance imaging: The effect of age, training, and coronary artery disease
28. Changes in left ventricular size, wall thickness and function in anemic patients treated with recombinant human erythropoietin
29. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy
30. Regression of left ventricular hypertrophy in hypertensive dialyzed uremic patients on long-term antihypertensive therapy
31. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension
32. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
33. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure. Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction
34. Brain natriuretic peptide as a marker for hypertensive left ventricular hyperthrophy: Changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor
35. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease. Comparative effects of ACE inhibition and calcium channel blockade
36. Antihypertensive effects and arterial haemodynamic alterations during angiotensin converting enzyme inhibition
37. Lisinopril reverses left ventricular hypertrophy through improved aortic compliance
38. Effect of hemodialysis on plasma levels of brain natriuretic peptide in patients with chronic renal failure
39. Plasma concentration of human natriuretic peptide in patients on hemodialysis